Related Experiment Video
Updated: Aug 5, 2026

08:29
A Cardiac Microphysiological System for Studying Ca2+ Propagation via Non-genetic Optical Stimulation
Published on: March 21, 2025
Artificial Intelligence Techniques in Cardiac Neuromodulation: Mechanisms, Applications, and Pathways to Clinical
Kshitiz Pandey1, Pratik Pandey2, Sushmita Khanal3
1College of Medical Sciences Teaching Hospital Chitwan Nepal.
Journal of Arrhythmia
|July 25, 2026
Summary
Artificial intelligence (AI) can personalize cardiac neuromodulation therapies. AI techniques address patient selection, stimulation control, and response monitoring challenges in cardiovascular disease management.
Area of Science:
- Cardiovascular Electrophysiology
- Biomedical Engineering
- Artificial Intelligence in Medicine
Background:
- Cardiac neuromodulation aims to correct autonomic imbalance in cardiovascular diseases using methods like vagus nerve stimulation.
- Landmark trials show variable patient responses and highlight issues like dosing and patient phenotyping.
- Individualized approaches are needed for patient selection, therapy delivery, and monitoring.
Purpose of the Study:
- To review artificial intelligence (AI) techniques applicable to cardiac neuromodulation.
- To map AI methods to challenges in patient selection, real-time control, and response monitoring.
- To discuss the potential of AI in advancing personalized cardiac neuromodulation.
Main Methods:
- Narrative review of seven AI families: supervised learning, deep learning, representation learning, reinforcement learning, multimodal fusion, AI-informed digital twins, and explainable AI with federated learning.
- Summarized AI methods, their relevance to cardiac neuromodulation problems, and existing evidence.
- Mapped AI techniques to patient selection, real-time stimulation control, and longitudinal response monitoring.
Main Results:
- Representation learning shows promise for identifying vagus nerve stimulation responders.
- Reinforcement learning is suitable for closed-loop vagus nerve stimulation control.
- AI-informed digital twins can facilitate in silico testing of stimulation protocols.
Conclusions:
- AI offers powerful tools to overcome limitations in current cardiac neuromodulation therapies.
- Translating AI methods from adjacent fields into clinical trials is a key opportunity.
- Personalized AI-driven approaches can improve outcomes in cardiovascular disease management.
